Research Article

Inhibition of Triggering Receptor Expressed on Myeloid Cell-1 Alleviates Acute Gouty Inflammation

Table 1

Clinical and laboratory characteristics of the subjects.

ItemsAGA ()IGA ()HC () value value

Age (years)0.740.478
Disease duration (years)NANANA
BMI (kg/m2)7.17<0.001
SBP (mmHg)1.940.07
DBP (mmHg)2.880.18
Tophi, (%)13 (19.70%)NANANANA
Renal calculus, (%)10 (15.15%)7 (11.67%)NANANA
Diabetes mellitus, (%)5 (7.58%)3 (5.00%)NANA-NA
ESR (mm/h)21.98<0.001
WBC (×109/L)6.61<0.001
Granulocyte (×109/L)34.13<0.001
Lymphocyte (×109/L)17.69<0.001
Monocyte (×109/L)39.72<0.001
TG (mmol/L)19.71<0.001
TC (mmol/L)3.990.194
HDL (mmol/L)8.39<0.001
LDL (mmol/L)6.920.0012
VLDL (mmol/L)16.53<0.001
Apo B100 (mmol/L)21.12<0.001
Glucose (mmol/L)20.52<0.001
Uric acid (μmol/L)69.85<0.001
CRP (mg/L)11.09<0.001

BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; ESR: erythrocyte sedimentation rate; WBC: white blood cell; TG: triglyceride; TC: total cholesterol; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; VLDL: very low-density lipoprotein cholesterol; Apo A1: Apolipoprotein A1; Apo B100: Apolipoprotein B100; CRP: C-reactive protein.